পদ্ধতির তুলনা করুন
নির্বাচিত পদ্ধতিগুলো পাশাপাশি পর্যালোচনা করুন; যে সারিগুলোয় পার্থক্য আছে সেগুলো চিহ্নিত করা হয়।
| ইন্টারন্যাশনাল প্রস্টেট সিম্পটম স্কোর× | রোগীর স্বাস্থ্য প্রশ্নাবলী-২× | |
|---|---|---|
| ক্ষেত্র | স্বাস্থ্য সেবা | স্বাস্থ্য সেবা |
| পরিবার | Process / pipeline | Process / pipeline |
| উদ্ভবের বছর≠ | 1992 | 2003 |
| প্রবর্তক≠ | American Urological Association (AUA) and International Prostate Symptom Score Committee | Kurt Kroenke, Robert L. Spitzer, and Janet B. Williams |
| ধরন≠ | Eight-item symptom severity questionnaire | Two-item depression screening instrument |
| মৌলিক উৎস≠ | Barry, M. J., Fowler, F. J., O'Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., & Mebust, W. K. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. Journal of Urology, 148(5), 1549-1557. DOI ↗ | Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41(11), 1284-1292. DOI ↗ |
| অপর নাম | IPSS, AUA Symptom Index | PHQ-2, Patient Health Questionnaire |
| সম্পর্কিত | 3 | 3 |
| সারসংক্ষেপ≠ | The International Prostate Symptom Score (IPSS) is a validated seven-item self-report instrument adopted by the World Health Organization and American Urological Association to measure the severity of lower urinary tract symptoms (LUTS) in men with suspected benign prostatic hyperplasia (BPH). The IPSS comprises items assessing frequency of nocturia, urgency, weak stream, hesitancy, intermittency, and incomplete emptying over the past month. It is the gold standard measure for BPH symptom severity assessment in clinical practice and research. | The Patient Health Questionnaire-2 (PHQ-2) is an ultra-brief, validated two-item screening instrument developed by Kroenke and colleagues in 2003 to identify major depression in primary care and medical populations. The PHQ-2 assesses the two cardinal symptoms of depression (depressed mood and anhedonia) over the past two weeks using a 0-3 frequency scale. It is the shortest validated depression screening tool enabling routine use in time-constrained clinical settings. |
| ScholarGateডেটাসেট ↗ |
|
|